{"id":7554,"date":"2022-01-05T17:03:32","date_gmt":"2022-01-06T01:03:32","guid":{"rendered":"https:\/\/rakuten-med.com\/us\/?post_type=press_releases&p=7554"},"modified":"2022-04-19T21:26:17","modified_gmt":"2022-04-20T04:26:17","slug":"rakuten-medical-to-present-at-the-40th-annual-j-p-morgan-healthcare-conference-on-january-10th-2022","status":"publish","type":"press_releases","link":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/","title":{"rendered":"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022"},"content":{"rendered":"

SAN DIEGO, Calif., Jan. 5, 2022 \/PRNewswire\/ — Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox\u2122, will present at the 40th Annual J.P. Morgan Healthcare Conference being held virtually January 10-13, 2022.<\/p>\n

 <\/p>\n

Rakuten Medical’s Vice Chairman and CEO, Mickey Mikitani, is scheduled to present virtually at approximately 10:30am PST, Monday, January 10. A live audio webcast of the presentation can be accessed by following this link<\/a>. Following the completion of the presentation, a full audio recording will be available in the News section of the Rakuten Medical, Inc website at https:\/\/rakuten-med.com\/us\/<\/a>.<\/p>\n

 <\/p>\n

About Rakuten Medical, Inc.\u00a0<\/strong><\/p>\n

Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision, cell-targeting investigational therapies on its\u00a0IlluminoxTM\u00a0<\/sup>platform, which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Outside of Japan, Illuminox\u2122\u00a0therapies have not yet been approved as safe or effective by any regulatory authority. The company\u2019s\u00a0first drug developed on the Illuminox\u2122 platform, ASP-1929, has received approval from the Japanese Ministry of Health,\u00a0Labour, and Welfare, and is currently the subject of a global phase 3 clinical trial for recurrent head and neck cancer. Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives. The company has\u00a06 locations in 5 countries,\u00a0including the United States, where it is headquartered, Japan, the Netherlands, Taiwan, and Switzerland. For more information, visit www.rakuten-med.com.<\/p>\n

 <\/p>\n

Rakuten Medical Public Relations:\u202f https:\/\/rakuten-med.com\/us\/contact\/<\/a><\/p>\n

SOURCE\u00a0Rakuten Medical, Inc.<\/p>\n

Release HERE<\/a><\/p>\n

Related Links:\u00a0 https:\/\/rakuten-med.com\/us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, Calif., Jan. 5, 2022 \/PRNewswire\/ — Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies […]<\/p>\n","protected":false},"author":2,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"class_list":{"0":"post-7554","1":"press_releases","2":"type-press_releases","3":"status-publish","5":"entry"},"yoast_head":"\nRakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022 - Rakuten Medical - To conquer cancer.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022 - Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Calif., Jan. 5, 2022 \/PRNewswire\/ — Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/\" \/>\n<meta property=\"og:site_name\" content=\"Rakuten Medical - To conquer cancer.\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-20T04:26:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2021\/02\/RakutenMedical_KV.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2022\\\/01\\\/05\\\/7554\\\/\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2022\\\/01\\\/05\\\/7554\\\/\",\"name\":\"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022 - Rakuten Medical - To conquer cancer.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\"},\"datePublished\":\"2022-01-06T01:03:32+00:00\",\"dateModified\":\"2022-04-20T04:26:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2022\\\/01\\\/05\\\/7554\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2022\\\/01\\\/05\\\/7554\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/news\\\/press-releases\\\/2022\\\/01\\\/05\\\/7554\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/\",\"name\":\"Rakuten Medical - To conquer cancer.\",\"description\":\"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rakuten-med.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022 - Rakuten Medical - To conquer cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/","og_locale":"en_US","og_type":"article","og_title":"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022 - Rakuten Medical - To conquer cancer.","og_description":"SAN DIEGO, Calif., Jan. 5, 2022 \/PRNewswire\/ — Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies […]","og_url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/","og_site_name":"Rakuten Medical - To conquer cancer.","article_modified_time":"2022-04-20T04:26:17+00:00","og_image":[{"width":1500,"height":900,"url":"https:\/\/rakuten-med.com\/us\/wp-content\/uploads\/sites\/6\/2021\/02\/RakutenMedical_KV.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/","url":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/","name":"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022 - Rakuten Medical - To conquer cancer.","isPartOf":{"@id":"https:\/\/rakuten-med.com\/us\/#website"},"datePublished":"2022-01-06T01:03:32+00:00","dateModified":"2022-04-20T04:26:17+00:00","breadcrumb":{"@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rakuten-med.com\/us\/news\/press-releases\/2022\/01\/05\/7554\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rakuten-med.com\/us\/"},{"@type":"ListItem","position":2,"name":"Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022"}]},{"@type":"WebSite","@id":"https:\/\/rakuten-med.com\/us\/#website","url":"https:\/\/rakuten-med.com\/us\/","name":"Rakuten Medical - To conquer cancer.","description":"Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox\u2122TM technology platform. We are committed to our mission to conquer cancer and aim to achieve a society where cancer patients can lead fulfilling lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rakuten-med.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases\/7554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/types\/press_releases"}],"author":[{"embeddable":true,"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/users\/2"}],"wp:attachment":[{"href":"https:\/\/rakuten-med.com\/us\/wp-json\/wp\/v2\/media?parent=7554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}